United States · FDA National Drug Code directory
Telmisartan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70756-312_28abd7a9-b660-4c91-b5f4-b65aa673fdbc
- Product NDC
- 70756-312
- Form
- TABLET
- Composition / generic term
- Telmisartan
- Labeler
- Lifestar Pharma LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241015
- Source listing expiry
- 20261231
Source-listed ingredients
- TELMISARTAN — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (70756-312-30) · 70756-312-30
- 10 BLISTER PACK in 1 CARTON (70756-312-99) / 10 TABLET in 1 BLISTER PACK (70756-312-01) · 70756-312-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →